Tech Company Financing Transactions

Tokai Pharmaceuticals Funding Round

Apple Tree Partners, Novartis Venture Fund and private investors invested in a $23 million Series D capital raise for Tokai Pharmaceuticals . The round was announced by the company on 9/20/2011.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

255 State St. 6th floor
Boston, MA 02109
USA

Phone

(617) 225-4305

Website

www.tokaipharmaceuticals.com

Email Address

Not Recorded

Overview

Tokai Pharmaceuticals (NASDAQ: TKAI) develops biopharmaceutical products that focus on endocrine treatment. The company is developing novel, proprietary therapies for prostate cancer and other hormonally-driven diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jodie Morrison

        

Chief Operating Officer

John McBride

        

Browse more venture capital transactions:

Prev: 9/20/2011: Credorax venture capital transaction
Next: 9/20/2011: RRKidz venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary